| Announce Date | 08/05/2025 |
| EPS Normalized Actual | $0.89 (Miss by $-0.38) |
| EPS GAAP Actual | $0.89 (Miss by $-0.38) |
| Revenue Actual | $0.833729B |
| Revenue Surprise | Beat by $833.729M |
| Announce Date | 10/01/2025 (Pre-Market) |
| EPS Normalized Estimate | $3.09333 |
| EPS GAAP Estimate | $3.09333 |
| Revenue Estimate | $1.1932B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2027 | 4.79 | 14.82 | 4.74119 | 4.83892 | 0 |
| Dec 2026 | 4.27 | 16.63 | 4.22649 | 4.31361 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | 0.89 | 0.16 | 0.833729B | 3.22% | 34.73M |
| FQ1 2025 (Mar 2025) | -1.21 | -0.41 | 0.353471B | 6.76% | 6.57M |
| FQ4 2024 (Dec 2024) | 0.41 | 0.41 | 0.6572B | 1.57% | 657.2M |
| FQ3 2024 (Sep 2024) | 2.62 | 2.62 | 1.1053B | 1.35% | 1105.3M |
| FQ2 2024 (Jun 2024) | 1.38 | 1.38 | 0.8069B | 100% | 806.9M |
| FQ1 2024 (Mar 2024) | -0.84 | -0.84 | 0.32959B | 100% | 329.59M |
| FQ3 2022 (Sep 2022) | 1.76 | 1.76 | 0.975428B | 100% | 975.43M |
| FQ4 2023 (Dec 2023) | 0.36 | 0.36 | 0.6469B | 16.91% | 646.9M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
3.09333
Consensus Revenue Estimates
1.1932B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.8 | -- | 0.75196 | 0.81734 | 2 |
| FQ3 2027 (Sep 2027) | 4.02 | -- | 3.73214 | 4.16473 | 1 |
| FQ2 2027 (Jun 2027) | 2.18 | -- | 2.0239 | 2.25848 | 1 |
| FQ1 2027 (Mar 2027) | -1.64 | -- | -1.67555 | -1.54153 | 2 |
| FQ4 2026 (Dec 2026) | 0.47 | -- | 0.45684 | 0.48391 | 1 |
| FQ3 2026 (Sep 2026) | 3.32 | -- | 3.22707 | 3.41828 | 1 |
| FQ2 2026 (Jun 2026) | 1.85 | 51.89 | 1.79822 | 1.90476 | 1 |
| FQ1 2026 (Mar 2026) | -0.77 | -57.14 | -0.79279 | -0.74845 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.85B | -- | 0.81B | 0.86B | 2 |
| FQ3 2027 (Sep 2027) | 1.46B | -- | 1.38B | 1.5B | 4 |
| FQ2 2027 (Jun 2027) | 1.08B | -- | 1.02B | 1.11B | 6 |
| FQ1 2027 (Mar 2027) | 0.46B | -- | 0.44B | 0.47B | 2 |
| FQ4 2026 (Dec 2026) | 1.35B | -- | 1.32B | 1.38B | 1 |
| FQ3 2026 (Sep 2026) | 1.32B | -- | 1.29B | 1.35B | 1 |
| FQ2 2026 (Jun 2026) | 1.29B | 35.38 | 1.26B | 1.32B | 1 |
| FQ1 2026 (Mar 2026) | 1.26B | 71.99 | 1.23B | 1.29B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | 0.73 | 0.89 | 0.16 | 17.98% |
| FQ1 2025 (Mar 2025) | -0.8 | -1.21 | -0.41 | 33.88% |
| FQ4 2024 (Dec 2024) | 0.41 | 0.41 | 100% | |
| FQ3 2024 (Sep 2024) | 2.62 | 2.62 | 100% | |
| FQ2 2024 (Jun 2024) | 1.38 | 1.38 | 100% | |
| FQ1 2024 (Mar 2024) | -0.84 | -0.84 | 100% | |
| FQ3 2022 (Sep 2022) | 1.76 | 1.76 | 100% | |
| FQ4 2023 (Dec 2023) | 0.36 | 0.36 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | $0.8B | $0.83B | $34.73M | 4.17% |
| FQ1 2025 (Mar 2025) | $0.35B | $0.35B | $6.57M | 1.86% |
| FQ4 2024 (Dec 2024) | $0B | $0.66B | $657.2M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $1.11B | $1105.3M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.81B | $806.9M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.33B | $329.59M | 100% |
| FQ3 2022 (Sep 2022) | $0B | $0.98B | $975.43M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0.65B | $646.9M | 100% |